Laboratory Safety Of Dupilumab In Pediatric Patients Aged >= 6-< 12 Years With Severe Atopic Dermatitis: Results From A Phase 3 Trial (Liberty Ad Peds)
ACTA DERMATO-VENEREOLOGICA(2021)
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
ACTA DERMATO-VENEREOLOGICA(2021)